maladies – Commercialisation d'un traitement contre la maladie d'Alzheimer

This written question concerns the commercialization of a treatment for Alzheimer's disease. It seeks information on the steps being taken to make this treatment available to patients. The question is posed by a Member of Parliament to the government, likely seeking details on regulatory approval, pricing, and accessibility of the Alzheimer's treatment.